{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:01:51Z","timestamp":1790373711499,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00228-020-02892-2","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:03:27Z","timestamp":1589616207000},"page":"1169-1174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Paradoxical adverse drug reactions: descriptive analysis of French reports"],"prefix":"10.1007","volume":"76","author":[{"given":"Yan","family":"Hakimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Petitpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-9341","authenticated-orcid":false,"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,16]]},"reference":[{"key":"2892_CR1","first-page":"173","volume":"35","author":"SW Smith","year":"2012","unstructured":"Smith SW, Hauben M, Aronson JK (2012) Paradoxical and bidirectional drug effects. Drug Saf 35:173\u2013189","journal-title":"Drug Saf"},{"key":"2892_CR2","first-page":"911","volume":"29","author":"M Hauben","year":"2006","unstructured":"Hauben M, Aronson JK (2006) Paradoxical reactions: under recognized adverse effects of drugs? Drug Saf 29:911\u20131010","journal-title":"Drug Saf"},{"key":"2892_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.therap.2019.09.004","volume":"74","author":"N Moore","year":"2019","unstructured":"Moore N, Berdai D, Blin P, Droz C (2019) Pharmacovigilance the next chapter. Therapie 74:557\u2013567","journal-title":"Therapie"},{"key":"2892_CR4","unstructured":"Introductory guide MedDRA. https:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/000354_intguide_22.1.pdf. Accessed 28\/10\/2019"},{"key":"2892_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255\u20131259","journal-title":"Lancet"},{"key":"2892_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.therap.2016.02.009","volume":"71","author":"G Miremont-Salam\u00e9","year":"2016","unstructured":"Miremont-Salam\u00e9 G, Th\u00e9ophile H, Haramburu F, B\u00e9gaud B (2016) Imputabilit\u00e9 en pharmacovigilance: de la m\u00e9thode fran\u00e7aise originelle aux m\u00e9thodes r\u00e9actualis\u00e9es. Therapie 71:171\u2013178","journal-title":"Therapie"},{"key":"2892_CR7","unstructured":"ATC Structure and principles. https:\/\/www.whocc.no\/atc\/structure_and_principles. Accessed 28\/10\/2019"},{"key":"2892_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2165\/00002018-200225070-00002","volume":"25","author":"A Figueras","year":"2002","unstructured":"Figueras A, Pedr\u00f3s C, Valsecia M, Laporte JR (2002) Therapeutic ineffectiveness: heads or tails? Drug Saf 25:485\u2013487","journal-title":"Drug Saf"},{"key":"2892_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00000446-200107000-00019","volume":"101","author":"MM Gutierez","year":"2001","unstructured":"Gutierez MM, Roper J, Pockhee H (2001) Paradoxical reactions to benzodiazepines: when to expect the unexpected. Am J Nurs 101:34\u201339","journal-title":"Am J Nurs"},{"key":"2892_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00003643-200112000-00002","volume":"18","author":"AA Weinbroum","year":"2001","unstructured":"Weinbroum AA, Szold O, Ogorek D, Flasishon R (2001) The midazolam-induced paradox phenomenon is reversible by flumazenil: epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol 18:789\u2013797","journal-title":"Eur J Anaesthesiol"},{"key":"2892_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2125.1981.tb01844.x","volume":"11","author":"RW Hall","year":"1981","unstructured":"Hall RW, Zisook S (1981) Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 11:99\u2013104","journal-title":"Br J Clin Pharmacol"},{"key":"2892_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00012995-200112000-00001","volume":"207","author":"CJ Davies","year":"2001","unstructured":"Davies CJ, Davies DM (2001) Paradoxical reactions to commonly used drugs. Adverse Drug React Bull 207:807\u2013810","journal-title":"Adverse Drug React Bull"},{"key":"2892_CR13","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1016\/j.joms.2010.06.176","volume":"68","author":"WS McKenzie","year":"2010","unstructured":"McKenzie WS, Rosenberg M (2010) Paradoxical reaction following administration of a benzodiazepine. J Oral Maxillofac Surg 68:3034\u20133036","journal-title":"J Oral Maxillofac Surg"},{"key":"2892_CR14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1592\/phco.24.13.1177.38089","volume":"24","author":"E Mancuso","year":"2004","unstructured":"Mancuso E, Tanzi G, Gabay M (2004) Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 24:1177\u20131185","journal-title":"Pharmacotherapy"},{"key":"2892_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","volume":"13","author":"G Fiorino","year":"2014","unstructured":"Fiorino G, Danese S, Pariente B, Allez M (2014) Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-\u03b1 agents. Autoimmun Rev 13:15\u201319","journal-title":"Autoimmun Rev"},{"key":"2892_CR16","first-page":"700","volume":"30","author":"C Joyau","year":"2012","unstructured":"Joyau C, Veyrac G, Dixneuf V, Jolliet P (2012) Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect? Clin Exp Rheumatol 30:700\u2013706","journal-title":"Clin Exp Rheumatol"},{"key":"2892_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X19841796","volume":"11","author":"R Del Giorno","year":"2019","unstructured":"Del Giorno R, Iodice A, Mangas C, Gabutti L (2019) New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review. Ther Adv Musculoskelet Dis 11:1\u20136","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2892_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15569520500536568","volume":"25","author":"E Dika","year":"2006","unstructured":"Dika E, Varotti C, Bardazzi F, Maibach HI (2006) Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol 25:1\u201311","journal-title":"Cutan Ocul Toxicol"},{"key":"2892_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/0004867415574749","volume":"49","author":"C Hsu","year":"2015","unstructured":"Hsu C, Lin C, Lu L, Hu L (2015) Risperidone exacerbates psychosis: a paradoxical phenomenon? Aust N Z J Psychiatry 49:669\u2013670","journal-title":"Aust N Z J Psychiatry"},{"key":"2892_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.psychres.2014.01.049","volume":"216","author":"G Fonda","year":"2014","unstructured":"Fonda G, MacGregorb A, Ducasseb D, Brittnerba M (2014) Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder. Psychiatry Res 216:286\u2013287","journal-title":"Psychiatry Res"},{"key":"2892_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s002130000532","volume":"152","author":"S Silvestri","year":"2000","unstructured":"Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ, Kapur S, Zipursky RB, Wilson AA, Christensen BK, Seeman P (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 152:174\u2013180","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02892-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-02892-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02892-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T23:09:07Z","timestamp":1621120147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-02892-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,16]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2892"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-02892-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,16]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}